Fig. 4From: A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancerTime to progression (a) and overall survival (b) curves in the subgroup of 6 patients who underwent secondary surgical resection of downsized diseaseBack to article page